Navigation Links
Siemens Expands Customer Return on Innovation at SNM 2011
Date:6/3/2011

SAN ANTONIO, June 3, 2011 /PRNewswire/ -- At the 2011 SNM Annual Meeting in San Antonio, Siemens Healthcare (booth #6033) will address the increasing demand for molecular imaging procedures and Siemens' efforts to expand molecular imaging's availability in three directions: patient access, clinical utilization, and new clinical applications. Through this benchmark-redefining growth of molecular imaging, Siemens (NYSE: SI) is "Expanding Your Return on Innovation."

(Logo: http://photos.prnewswire.com/prnh/20070904/SIEMENSLOGO)

Expanded Clinical Utilization

Two of the most challenging issues facing physicians who are expanding their clinical utilization of molecular imaging scanners are the dual mandates to improve patient safety and increase productivity. Siemens is meeting both of these core needs through its commitment to minimizing dose while maximizing speed. Siemens offers innovative solutions where the lowest dose can be used, while still scanning patients faster than ever.

Symbia® IQ-SPECT technology, which recently received the 2011 North American Nuclear Cardiology Product Differentiation Excellence of the Year Award from the business research and consulting firm of Frost & Sullivan, enables routine scans using half dose and double speed. Its proven technologies provide a comprehensive cardio workup, while easing the burden of the global molybdenum shortage via a reduction in technetium dose. Diagnostic SPECT-CT, including calcium scoring, uses half of the typical technetium dose and cuts acquisition time from approximately 20 minutes to less than five minutes with the addition of IQ-SPECT.

With technologies such as TrueV and ultraHD-PET, where the axial field of view is increased by 33%, and 2mm uniform resolution across the entire field of view is achieved, along with two times improvement in signal to
'/>"/>

SOURCE Siemens Healthcare
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. At SIIM 2011 Siemens Showcases Imaging IT Solutions for Driving Greater Value in Radiology and Other Specialties
2. Siemens Honored by Department of Defense Agency for Supporting Massachusetts Guardsman
3. Siemens Showcases New Innovations in Clinical Diagnostics, Automation, and IT at IFCC-WorldLab Berlin 2011
4. Siemens Applauds First Health System Customers to Successfully Attest to Meaningful Use
5. Siemens Demonstrates Strategy for Sustainable Cardiovascular Care
6. Oconee Medical Center is Winner of Siemens Who Inspires You? Video Contest
7. Siemens Appoints Overhage as New Chief Medical Informatics Officer
8. Siemens Launches PEP, a Personalized Education Plan for Clinical Laboratory and Healthcare Professionals
9. VIDEO From Siemens and Synaptic Digital: Not Your Fathers X-Ray Machine
10. VIDEO from Siemens Corporation Available on thenewsmarket.com: Amazing Medical Images: Diagnosing in the Digital Age
11. Cymetrix Forms Alliance With Siemens Healthcare for System Conversion Support
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013   Life Technologies ... a licensing agreement granting Suzhou Ribo Life Sciences ... siRNA therapeutics in China ... formulate proprietary siRNA molecules in combination with Invivofectamine® ... address human diseases with high unmet medical need ...
(Date:6/19/2013)... , 19. Juni 2013 ... mit der Entwicklung von SCS microRESIST™, ... in der Beschichtung mit Parylene gelungen ... von biokompatiblem Parylene mit antimikrobiellen Eigenschaften ... schädlicher Mikroorganismen auf beschichteten medizinischen Geräten. ...
(Date:6/18/2013)... , June 18, 2013  Intercept Pharmaceuticals, Inc.  ... company focused on the development and commercialization of novel ... announced the pricing of an underwritten public offering of ... offering price of $33.01 per share.  In addition, Intercept ... up to an additional 259,500 shares of common stock. ...
Breaking Medicine Technology:Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
... All pre-specified subset analyses of progression-free survival,in the ... in,relative risk of disease progression for patients receiving,satraplatin. ... as presence or absence of pain. -- The ... - radiologic,progression and pain progression - were each ...
... ,Abstracts: 2000, 2002 , CHICAGO/DARMSTADT, Germany, June 4, ... today at the American Society of,Clinical Oncology (ASCO) ... cilengitide in patients with newly diagnosed,glioblastoma – a ... highly selective integrin inhibitor targeting the,tumor and its ...
Cached Medicine Technology:Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 2Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 3Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 4Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 5Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 6Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 7Merck at ASCO 2007: Encouraging Results in Progression-Free,Survival in Patients With Aggressive Brain Tumors (glioblastoma),Using Cilengitide in Phase I/IIa Study 2Merck at ASCO 2007: Encouraging Results in Progression-Free,Survival in Patients With Aggressive Brain Tumors (glioblastoma),Using Cilengitide in Phase I/IIa Study 3Merck at ASCO 2007: Encouraging Results in Progression-Free,Survival in Patients With Aggressive Brain Tumors (glioblastoma),Using Cilengitide in Phase I/IIa Study 4Merck at ASCO 2007: Encouraging Results in Progression-Free,Survival in Patients With Aggressive Brain Tumors (glioblastoma),Using Cilengitide in Phase I/IIa Study 5
(Date:6/19/2013)... 19, 2013 Brightree LLC , ... software solutions for the post-acute care industry, has been ranked ... the Healthcare Informatics 100 (HCI 100) list. This ... the U.S. in terms of revenue during the last fiscal ... rate of 85% annually, and the company has built its ...
(Date:6/19/2013)... Boca Raton, FL (PRWEB) June 19, 2013 ... spoke about the positive changes and growth that has occurred ... his nationwide travel club. , Shuman said, "Travel Services has ... program to heights beyond belief. Membership is up, even ... agents to meet the demands of members." , Having been ...
(Date:6/19/2013)... disease Amyotrophic lateral sclerosis (ALS), also known as Lou ... can be classified into four distinct stages, report pathologists ... of Pennsylvania in the Annals of Neurology . ... tissues shows, for the first time, how the fatal ... the central nervous system to other regions of brain ...
(Date:6/19/2013)... derived from a naturally occurring compound (apocynin), has ... with Parkinson,s Disease symptoms by preventing deficits in ... the May 28, 2013 edition of ... postdoctoral fellow at the Medical College of Wisconsin ... Balaraman Kalyanaraman, Ph.D., Harry R. & Angeline ...
(Date:6/19/2013)... Imprivata ®, a leading global provider ... Imprivata OneSign ® leads the single sign-on (SSO) category ... & Services report . CIOs and other healthcare executives ... performance of its products and the quality of its ... is integral to their long-term healthcare IT strategy. ...
Breaking Medicine News(10 mins):Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 2Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 3Health News:Former Owner Eric Shuman Endorses New Owners and Changes Made in Last Year Since Shuman Sold Travel Services Center at Member Conference 2Health News:Staging system in ALS shows potential tracks of disease progression, Penn study finds 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 3
... one of the worlds leading causes of blindness could be ... discovery here. , In experiments with laboratory rats, scientists at ... a potential new therapy for uveitis the inflammation of ... the outer surface of the eyeball and includes the iris. ...
... ... Sept. 28 Registered nurses at up to 16,Northern California hospitals, ... strike in October that could involve up to 5,500 RNs at,facilities ... Yuba City and Marysville. Strike notices are being sent today ...
... VAWith extensively drug-resistant tuberculosis, life-threatening drug-resistant respiratory and ... headlines, infectious diseases physicians are applauding Rep. Jim ... introducing H.R. 3697, the Strategies To Address Antimicrobial ... The STAAR Act has the potential to save ...
... 28 Healthcare,Technologies Ltd. (NASDAQ: HCTL ), ... meeting of its shareholders for the approval of,the ... Bioventures,Inc. and Gamida for Life B.V., originally scheduled ... to allow shareholders additional time to fully consider,the ...
... Curtail Infant,Deaths, WASHINGTON, Sept. 28 The ... new civil rights issue" and,requires a revised set ... by the Joint Center for Political and Economic,Studies., ... to Love: Infant Mortality,Commission, which was established by ...
... program is improving air quality, agency claims , , FRIDAY, ... (NOx) from power plants, cars and other industry are ... for less ozone and therefore less smog and healthier ... NOx Budget Trading Program annual report from the U.S. ...
Cached Medicine News:Health News:New discovery may improve treatment of one of the world's leading causes of blindness 2Health News:RNs to Announce October Strike of 5,500 Nurses 2Health News:Infectious diseases experts applaud bill against 'bad bugs' 2Health News:Healthcare Technologies to Reschedule the Shareholders Meeting to Approve the NexGen Biofuels Transaction 2Health News:Healthcare Technologies to Reschedule the Shareholders Meeting to Approve the NexGen Biofuels Transaction 3Health News:Joint Center Says New Approach Required to Reduce Black Infant Mortality 2Health News:Joint Center Says New Approach Required to Reduce Black Infant Mortality 3Health News:Less Smog Now in Eastern U.S.: EPA 2
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
... BD Beaver Clear Cornea Incision System ... specifically for the Cataract surgeon. The System ... an alternative to costly diamond knives. ... shield that is designed to both protects ...
... Carl Zeiss Meditec's technological expertise ... retinal disease became apparent with revolutionary ... system. Now, with the introduction of ... expertise is being applied to high-resolution, ...
... the eyeglasses in the EZ Meter and ... automatically display the measurement results on its ... detection to data printout makes this the ... and private offices.,In addition to being extremely ...
Medicine Products: